Advanced Filters
noise

Athlete's Foot Clinical Trials

A listing of Athlete's Foot medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 385 clinical trials
D Daruka Mahadevan, MD

SLV-154 Treatment of Metastatic Solid Tumors

This is a Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, pharmacodynamics, immunogenicity, and efficacy of SLV-154 across a range of dose levels when administered to subjects with metastatic solid tumors.

18 years of age All Phase 1
J Jannet Beukema

Standard Follow-up Program Cervix Cancer (SFP CERVIX)

Standard evaluation and follow-up data regarding complications of curative radiation treatment for cervical cancer.

years of age Female Phase N/A

Role Of Colposcopy In Evaluation Of Suspicious Cervix

do colposcopy and cervical punch biopsy then compare between findings

18 - 60 years of age Female Phase N/A
V VALENTINA LANCELLOTTA

Evaluation of Ultraaccelerated High Dose Rate Intrauterine Interventional Radiotherapy

To evaluate the degree of acute and long-term intestinal, urinary and vaginal toxicity, and the impact on sexual activity of an accelerated fractionation of high dose rate interventional radiotherapy (IRT-HDR) in patients with locally advanced cervical cancer (IB2 - VA, N+/-).

18 years of age Female Phase N/A
Y Yong Li

Study on the Relationship Between Plasma MRD and cfDNA HPV and the Efficacy and Prognosis of Locally Advanced Cervical Cancer After Concurrent Chemoradiotherapy

Cervical cancer CC is the most common malignant tumor in the female reproductive system, seriously endangering women's health and life, and is one of the leading causes of death for women worldwide.Globally, HPV causes about 85% of cervical cancers and about 60% of oropharyngeal cancers, causing more than 500,000 cancers …

18 - 75 years of age Female Phase N/A

Effect of Different Treatments on the Prognosis of Early Cervical Cancer: A Multicenter, Prospective, Real-world Study

To observe the effects of different treatments on the oncological outcome and complications of early cervical cancer (2018 FIGO stage IA1 with lymphovascular space invasion and IA2-IIA2 cervical cancer). This study prospectively collecting enrolled cervical cancer patients clinical data and outcome from June 2020 to June 2025. (Classification factors: preoperative …

18 years of age Female Phase N/A

Cervical Cancer Screening With NGS-HPV Technology Based on Menstrual Blood

Our study is conducted to recruit cervical cancer screening patients to evaluate the application value of using high-throughput sequencing technology to detect HPV in menstrual blood for cervical cancer screening.

20 - 55 years of age Female Phase N/A
Y Yogesh Verma, MD

Impact of HPV Vaccination on Prevention of Cervical HPV Infection in Sikkim, India

This project aims is to monitor the effectiveness of HPV vaccination in real-word conditions, at least 7 years after initiation of HPV vaccination in Sikkim. This study would give an opportunity to provide rapid feedback to the Indian public health authorities about the impact of the HPV vaccine.

18 - 22 years of age Female Phase N/A

Community, Home-based Education, Screening Services Strategy to Increase Cervical Cancer Control Access for HIV-Positive Women in Nigeria

The goal of this observational study is to focus on adapting and implementing a program to promote HPV and cervical cancer (CC) screening and follow-up treatment for HIV-positive women, with three specific aims: Adaptation: Use stakeholder deliberation to tailor the successful MoMent program for this population. Implementation and Assessment: Deploy …

25 - 50 years of age Female Phase N/A
M Mette tranberg Nielsen, phd

Screening Triage and Risk Stratification

To investigate the performance of cytology, extended genotyping, p16/Ki67 dual stain cytology, DNA methylation and viral load as triage markers in post-menopausal HPV-screen-positive women aged 50-64 years in the organized screening program to predict the risk of developing CIN2+. (work package 1) To investigate the performance of cytology, extended genotyping, …

23 - 64 years of age Female Phase N/A

Simplify language using AI